Schering-Plough Reports Financial Results for First Quart...(adjustments pre-tax ...)

pre-tax 691 -

Income tax benefit 91 -

Total purchase accounting adjustments $600 $ -

Acquisition-related items:

Acquisition-related gains on currency-related

items (d) $- $(3)

Integration-related activities (e) 23 1

Total acquisition-related items, pre-tax 23 (2)

Income tax benefit 2 -

Total acquisition-related items $21 $(2)

Other specified items:

(Gain) on sale of manufacturing plant (d) (17) -

Upfront R&D payments (c) - 96

Total other specified items, pre-tax (17) 96

Income tax expense (5) -

Total other specified items $(12) $96

Total purchase accounting adjustments,

acquisition-related items and other specified

items $609 $94

(a) Included in cost of sales

(b) Included in cost of sales, general and administrative and research

and development

(c) Included in research and development

(d) Included in other expense/(income), net

(e) Included in special and acquisition-related charges

SCHERING-PLOUGH CORPORATION

Report for the period ended March 31 (unaudited):

GAAP Net Sales by Key Product

(Dollars in millions) First Quarter

2008 2007 %

HUMAN PRESCRIPTION PHARMACEUTICALS a/ $3,557 $2,398
'/>"/>